AI assistant
Sending…
Marvel Biosciences Corp. — AGM Information 2022
Dec 22, 2022
47732_rns_2022-12-22_b2c128c4-7a21-4d85-9077-a558768778f4.pdf
AGM Information
Open in viewerOpens in your device viewer

December 22, 2022
Filed via SEDAR
To All Applicable Exchanges and Securities Administrators
Subject: Marvel Biosciences Corp. (the "Issuer") Notice of Meeting and Record Date
Dear Sir/Madam:
We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:
| Meeting Type: | Annual General and Special Meeting |
|---|---|
| Meeting Date: | February 28, 2023 |
| Record Date for Notice of Meeting: | January 20, 2023 |
| Record Date for Voting (if applicable): | January 20, 2023 |
| Beneficial Ownership Determination Date: | January 20, 2023 |
| Class of Securities Entitled to Vote: | Common |
| ISIN: | CA57384M1077 |
| Issuer sending proxy materials directly to NOBOs: | No |
| Issuer paying for delivery to OBOs: | No |
| Notice and Access for Beneficial Holders: | No |
| Notice and Access for Registered Holders: | No |
In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.
Yours truly,
Odyssey Trust Company as agent for Marvel Biosciences Corp.
More from Marvel Biosciences Corp.
Remuneration Information
2026
May 20
Capital/Financing Update
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 27
Investor Presentation
2026
Apr 23
Regulatory Filings
2026
Apr 23
Capital/Financing Update
2026
Apr 17
Regulatory Filings
2026
Apr 16
Capital/Financing Update
2026
Apr 13